Shareholding disclosure

Novartis AG

Declared position

4.86%

Threshold

Crossed upwards

Timeline

Published

31.08.2022

Transaction

29.08.2022

Voting rights breakdown

Voting rights acquired4.86%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAM8U00017

Beneficial owner

Novartis AG

Declared address

Novartis AG, Basel

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Novartis AG

Molecular Partners AG31.08.2022TAM8U00017

Disclosure summary

Novartis AG disclosed a holding in Molecular Partners AG on the acquisition side, published by SIX Exchange Regulation on 31.08.2022, at 4.86% of voting rights. Notice category: Single shareholder.

Disclosed position

4.86%

Voting rights acquired

Voting rights acquired4.86%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Novartis AG disclosed a holding in Molecular Partners AG, published on 31.08.2022.

Publication date31.08.2022

Transaction date29.08.2022

Issuing companyMolecular Partners AG

Beneficial ownerNovartis AG

Declared addressNovartis AG, Basel

CategorySingle shareholder

Voting rights acquired4.86%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAM8U00017

Commercial register

CHE-103.867.266

Registered

Zefix record

Source: SIX Exchange Regulation · Publication date: 31.08.2022

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open